Dr. Rick Adachi is a professor of medicine at McMaster University and a staff rheumatologist at St. Joseph’s Healthcare Hamilton. He is also the inaugural holder of the Alliance for Better Bone Health Chair in Rheumatology. He is a graduate of McMaster University and has received his fellowship in Internal Medicine and in Rheumatology. Dr. Adachi is a member of the Scientific Advisory Council of Osteoporosis Canada and is a member of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF). Recently he was re-elected to the IOF Board of Directors. Dr. Adachi has conducted many clinical trials and has published extensively on a wide variety of therapies for the prevention and treatment of postmenopausal and corticosteroid-induced osteoporosis. He has participated in epidemiologic research assisting in the development of large databases looking at a wide variety of risk factors and therapies in osteoporosis. Dr. Adachi has participated in the development of guidelines for the treatment of primary and corticosteroid-induced osteoporosis in Canada. Dr. Adachi was awarded the First Annual Phillip Rosen Award in Rheumatology when he completed his training in Rheumatology. More recently Dr. Adachi was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he was awarded the Alliance for Better Bone Health Chair in Rheumatology at McMaster University and received the North American Menopause Society award for Innovation in Osteoporosis Research.

Research Interests: The Canadian Multicentre Osteoporosis Study (random sample of 10,000 subjects followed for 10 years to assess risk for osteoporosis and fractures); the structural analysis of bone and cartilage in bone and cartilage as measured by pQCT and pMRI; clinical trials in osteoporosis.

Dr. Rick Adachi is a professor of medicine at McMaster University and a staff rheumatologist at St. Joseph’s Healthcare Hamilton. He is also the inaugural holder of the Alliance for Better Bone Health Chair in Rheumatology. He is a graduate of McMaster University and has received his fellowship in Internal Medicine and in Rheumatology. Dr. Adachi is a member of the Scientific Advisory Council of Osteoporosis Canada and is a member of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF). Recently he was re-elected to the IOF Board of Directors. Dr. Adachi has conducted many clinical trials and has published extensively on a wide variety of therapies for the prevention and treatment of postmenopausal and corticosteroid-induced osteoporosis. He has participated in epidemiologic research assisting in the development of large databases looking at a wide variety of risk factors and therapies in osteoporosis. Dr. Adachi has participated in the development of guidelines for the treatment of primary and corticosteroid-induced osteoporosis in Canada. Dr. Adachi was awarded the First Annual Phillip Rosen Award in Rheumatology when he completed his training in Rheumatology. More recently Dr. Adachi was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he was awarded the Alliance for Better Bone Health Chair in Rheumatology at McMaster University and received the North American Menopause Society award for Innovation in Osteoporosis Research.

Research Interests: The Canadian Multicentre Osteoporosis Study (random sample of 10,000 subjects followed for 10 years to assess risk for osteoporosis and fractures); the structural analysis of bone and cartilage in bone and cartilage as measured by pQCT and pMRI; clinical trials in osteoporosis.